Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
DATA-HD Study	STARTED	Standard Dose Teriparatide	39
DATA-HD Study	STARTED	High Dose Teriparatide	37
DATA-HD Study	COMPLETED	Standard Dose Teriparatide	31
DATA-HD Study	COMPLETED	High Dose Teriparatide	29
DATA-HD Study	NOT COMPLETED	Standard Dose Teriparatide	8
DATA-HD Study	NOT COMPLETED	High Dose Teriparatide	8
DATA-HD Extension	STARTED	Standard Dose Teriparatide	27
DATA-HD Extension	STARTED	High Dose Teriparatide	26
DATA-HD Extension	COMPLETED	Standard Dose Teriparatide	26
DATA-HD Extension	COMPLETED	High Dose Teriparatide	26
DATA-HD Extension	NOT COMPLETED	Standard Dose Teriparatide	1
DATA-HD Extension	NOT COMPLETED	High Dose Teriparatide	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02176382/flow